Poor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy.
作者信息
Lawn Stephen D, Wood Robin
出版信息
Clin Infect Dis. 2011 Jun;52(11):1384-7. doi: 10.1093/cid/cir239.
Abstract
摘要
相似文献
1
Poor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy.
Clin Infect Dis. 2011 Jun;52(11):1384-7. doi: 10.1093/cid/cir239.
2
Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
Clin Infect Dis. 2011 Jun;52(11):1374-83. doi: 10.1093/cid/cir230.
3
A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL.
J Infect Dis. 2011 Sep 15;204(6):884-92. doi: 10.1093/infdis/jir503.
4
Maternal and infant outcomes with concurrent treatment of tuberculosis and HIV infection in pregnant women.
J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):e63-7. doi: 10.1097/QAI.0b013e318201e11d.
5
Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
Trials. 2011 Feb 2;12:25. doi: 10.1186/1745-6215-12-25.
6
Optimal treatment of Codisease due to HIV and tuberculosis.
J Infect Dis. 2011 Sep 15;204(6):817-9. doi: 10.1093/infdis/jir418.
7
A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis.
AIDS. 2007 Jan 30;21(3):381-2. doi: 10.1097/QAD.0b013e328011981a.
8
Complications of HIV disease and antiretroviral therapy.
Top Antivir Med. 2011 May-Jun;19(2):58-68.
9
Diagnosis and management of tuberculous meningitis in HIV-infected pediatric patients.
Pediatr Infect Dis J. 2009 Feb;28(2):147-8. doi: 10.1097/INF.0b013e318198d0b0.
10
Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count.
Clin Infect Dis. 2010 Aug 1;51(3):359-62. doi: 10.1086/654799.
引用本文的文献
1
Prevalence, incidence, and case fatality of tuberculous meningitis in adults living with HIV: a systematic review and meta-analysis.
BMC Public Health. 2024 Aug 7;24(1):2145. doi: 10.1186/s12889-024-19683-4.
2
A retrospective study of tuberculosis prevalence and associated factors among HIV-positive key populations in Nigeria.
PLOS Glob Public Health. 2024 Jul 12;4(7):e0003461. doi: 10.1371/journal.pgph.0003461. eCollection 2024.
3
Advances in Antiretroviral Therapy for Patients with Human Immunodeficiency Virus-Associated Tuberculosis.
Viruses. 2024 Mar 23;16(4):494. doi: 10.3390/v16040494.
4
Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis.
BMC Infect Dis. 2016 Jun 21;16:306. doi: 10.1186/s12879-016-1625-9.
5
Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
Pediatr Infect Dis J. 2013 Nov;32 Suppl 2(0 2):i-KK4. doi: 10.1097/01.inf.0000437856.09540.11.
6
Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.
AIDS. 2012 Nov 13;26(17):2121-33. doi: 10.1097/QAD.0b013e3283565dd1.
本文引用的文献
1
Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
Clin Infect Dis. 2011 Jun;52(11):1374-83. doi: 10.1093/cid/cir230.
2
Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections.
Curr Opin Infect Dis. 2011 Feb;24(1):34-42. doi: 10.1097/QCO.0b013e3283420f76.
3
Rapid molecular detection of tuberculosis and rifampin resistance.
N Engl J Med. 2010 Sep 9;363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1.
4
Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study.
BMJ. 2010 Sep 6;341:c4451. doi: 10.1136/bmj.c4451.
5
Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources.
Lancet Infect Dis. 2010 Jul;10(7):489-98. doi: 10.1016/S1473-3099(10)70078-5.
6
The HIV-associated tuberculosis epidemic--when will we act?
Lancet. 2010 May 29;375(9729):1906-19. doi: 10.1016/S0140-6736(10)60409-6. Epub 2010 May 18.
7
Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.
Clin Infect Dis. 2010 Jun 1;50(11):1532-8. doi: 10.1086/652652.
8
Timing of initiation of antiretroviral drugs during tuberculosis therapy.
N Engl J Med. 2010 Feb 25;362(8):697-706. doi: 10.1056/NEJMoa0905848.
9
Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.
Curr Opin HIV AIDS. 2010 Jan;5(1):18-26. doi: 10.1097/COH.0b013e328333850f.
10
Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.
Clin Chest Med. 2009 Dec;30(4):685-99, viii. doi: 10.1016/j.ccm.2009.08.010.
Zotero 插件